CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- 4 Open-market sale Chief Technology Officer sold 25,000 shares at $19.44 ($486,000)
- 4 Open-market sale President and CEO sold 64,821 shares at an average $18.77 ($1,216,774)
- 4 Shares withheld for taxes EVP and General Counsel gave up 736 shares (to pay taxes)
- 4 Open-market sale Director sold 22,106 shares at $11.65 ($257,535)
- 4 Shares withheld for taxes Chief Technology Officer gave up 1,517 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 919 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 4,779 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 1,517 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 181 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 667 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 181 shares (to pay taxes)
- 4 Open-market sale Director sold 25,000 shares at $11.26 ($281,500)
- 4 Open-market sale EVP & Chief Commercial Officer sold 2,857 shares at $12.31 ($35,170)
- 4 Shares withheld for taxes President and CEO gave up 1,848 shares (to pay taxes)
- 4 Open-market sale Director sold 25,000 shares at an average $11.37 ($284,246)
- 4 Open-market sale President and CEO sold 13,287 shares at an average $11.56 ($153,587)
- 4 Open-market sale Director sold 25,000 shares at an average $12.84 ($321,042)
- 4 Grant or award Director acquired 4,707 shares (grant or award)
- 4 Grant or award Director acquired 4,707 shares (grant or award)
- 4 Grant or award Director acquired 4,707 shares (grant or award)
Page 13 of 21 · 415 filings